|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Heron Therapeutics (NASDAQ: HRTX) through any online brokerage.
The latest price target for Heron Therapeutics (NASDAQ: HRTX) was reported by SVB Leerink on December 2, 2020. The analyst firm set a price target for 24.00 expecting HRTX to rise to within 12 months (a possible 134.15% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Heron Therapeutics (NASDAQ: HRTX) is $10.25 last updated Tue Oct 26 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Heron Therapeutics.
Heron Therapeutics’s $Q3 earnings are confirmed for after-market on $November 8, 2021.
There is no upcoming split for Heron Therapeutics.
Heron Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.